Christopher W. Cain

Insider Reports History

Entity: Individual
Location: 2001 Market Street, Suite 2500, Philadelphia, PA
Signature: /s/ Elizabeth Balta, as attorney-in-fact for Christopher W. Cain
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher W. Cain:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Cogent Biosciences, Inc.	Director	Stock Option (Right to Buy)	44.7K	$321K	$7.19	Jun 5, 2024	Direct
Viridian Therapeutics, Inc.\DE	Director	Stock Option (Right to Buy)	42K			Mar 10, 2025	Indirect
Aerovate Therapeutics, Inc.	Director	Stock Option (Right to Buy)	23K			Apr 29, 2025	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by Christopher W. Cain

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
JBIO	Jade Biosciences, Inc.	Apr 29, 2025	1	$0	4	May 1, 2025	Director
JBIO	Jade Biosciences, Inc.	Apr 28, 2025	0	$0	3	May 1, 2025	Director
VRDN	Viridian Therapeutics, Inc.\DE	Mar 10, 2025	1	$0	4	Mar 12, 2025	Director
VRDN	Viridian Therapeutics, Inc.\DE	Mar 10, 2025	0	$0	3	Mar 12, 2025	Director
COGT	Cogent Biosciences, Inc.	Jun 5, 2024	1	$0	4	Jun 13, 2024	Director
COGT	Cogent Biosciences, Inc.	Jun 7, 2023	1	$0	4	Jun 8, 2023	Director
COGT	Cogent Biosciences, Inc.	Jun 7, 2022	1	$0	4	Jun 9, 2022	Director